From Huntsville, Alabama, USA:
I know the clinical studies were done to compare Lantus (long acting) to NPH (intermediate acting). Wouldn't the more pertinent study be to compare a long acting (Lantus) insulin to a long acting (Lente or Ultralente) insulin? Can you tell me the advantages/disadvantages of Lantus as compared to Lente or Ultralente?
There are studies that compare Lantus (insulin glargine) to Ultralente. The most important differences for Lantus, compared to all other insulins are the time course (more flat) and the activity curve (more predictable). Lantus is flatter than both U and NPH. It is also more predictable, that is, more likely to work the same from day to day. That unpredictability of the older insulins is a major problem. We can't know how it will work from day to day. Lantus seems better, but only time will truly tell.
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:09:22
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.